Display options
Cite
Muhsen K, Maimon N, Mizrahi A, et al. Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel. N Engl J Med. 2021;doi: 10.1056/NEJMc2117385.
Muhsen, K., Maimon, N., Mizrahi, A., Varticovschi, B., Bodenheimer, O., Gelbshtein, U., Grotto, I., Cohen, D., & Dagan, R. (2021). Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel. The New England journal of medicine, . https://doi.org/10.1056/NEJMc2117385
Muhsen, Khitam, et al. "Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMc2117385
Muhsen K, Maimon N, Mizrahi A, Varticovschi B, Bodenheimer O, Gelbshtein U, Grotto I, Cohen D, Dagan R. Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel. N Engl J Med. 2021 Dec 22; doi: 10.1056/NEJMc2117385. Epub 2021 Dec 22. PMID: 34936758; PMCID: PMC8757568.
Copy Download .nbib Format: NLM
Share it on

N Engl J Med. 2021 Dec 22; doi: 10.1056/NEJMc2117385. Epub 2021 Dec 22.

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.

The New England journal of medicine

Khitam Muhsen, Nimrod Maimon, Ami Mizrahi, Baruch Varticovschi, Omri Bodenheimer, Udi Gelbshtein, Itamar Grotto, Dani Cohen, Ron Dagan

Affiliations

  1. Tel Aviv University, Tel Aviv, Israel [email protected].
  2. Soroka University Medical Center, Beer-Sheva, Israel.
  3. Israeli Ministry of Health, Airport City, Israel.
  4. Israeli Ministry of Health, Jerusalem, Israel.
  5. Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  6. Tel Aviv University, Tel Aviv, Israel.

PMID: 34936758 PMCID: PMC8757568 DOI: 10.1056/NEJMc2117385

[No abstract available.]

References

  1. Intern Med J. 2020 Sep;50(9):1033-1036 - PubMed
  2. N Engl J Med. 2021 Oct 7;385(15):1393-1400 - PubMed
  3. N Engl J Med. 2021 Dec 9;385(24):e84 - PubMed
  4. Clin Infect Dis. 2021 Oct 26;: - PubMed

Publication Types